One-Pot Three-Component Synthesis and Molecular Docking of Some Novel 2-Thiazolyl Pyridines as Potent Antimicrobial Agents. 2019

Fathy M Abdelrazek, and Sobhi M Gomha, and Mohamed E B Shaaban, and Kamal A Rabee, and Heba N El-Shemy, and Abanoub M Abdallah, and Peter Metz
Chemistry Department, Faculty of Science, Cairo University, Cairo 12613, Egypt.

BACKGROUND Thiazoles and pyridines are versatile synthetic scaffolds possessing wide spectrum of biological effects including potential antimicrobial activity. OBJECTIVE In the efforts to develop suitable antimicrobia drugs, medicinal chemists have focused on thiazole derivatives. A novel series of 2-thiazolyl pyridines was prepared in a one-pot three-component reaction using 2-bromoacetyl pyridine as a starting precursor. METHODS Structure of the synthesized compounds was elucidated by spectral data (FT-IR, 1H NMR, 13C NMR, and mass) and elemental analyses. The prepared compounds were screened for their in vitro antimicrobial activity. RESULTS The results revealed that compounds 4a,b,e-g and 12 showed promising activity. Molecular docking studies using MOE software were carried out for compounds 4a and 4b which exhibited potent activities indicated by the diameter zones (4a; 3.6, 4.0, 1.2 mm) (4b; 4.2, 3.5, 1.5 mm) and the binding affinities (4a; -5.7731, -5.3576, -4.6844 kcal mol-1) (4b; -5.9356, -2.8250, -5.3628 kcal mol-1) against Candida albicans, Bacillus subtilis and Escherichia coli, respectively. CONCLUSIONS This paper describes a facile and efficient MCR for synthesis of 2-thiazolyl pyridines from reaction of 2-bromoacetyl pyridine with different reagents. There was an agreement between the values of binding affinities and interactions and the data obtained from the practical antimicrobial screening of the tested compounds.

UI MeSH Term Description Entries
D011725 Pyridines Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.
D002176 Candida albicans A unicellular budding fungus which is the principal pathogenic species causing CANDIDIASIS (moniliasis). Candida albicans var. stellatoidea,Candida stellatoidea,Dematium albicans,Monilia albicans,Myceloblastanon albicans,Mycotorula albicans,Parasaccharomyces albicans,Procandida albicans,Procandida stellatoidea,Saccharomyces albicans,Syringospora albicans
D002177 Candidiasis Infection with a fungus of the genus CANDIDA. It is usually a superficial infection of the moist areas of the body and is generally caused by CANDIDA ALBICANS. (Dorland, 27th ed) Candida Infection,Moniliasis,Candida Infections,Candidiases,Infection, Candida,Moniliases
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D004927 Escherichia coli Infections Infections with bacteria of the species ESCHERICHIA COLI. E coli Infections,E. coli Infection,Infections, E coli,Infections, Escherichia coli,E coli Infection,E. coli Infections,Escherichia coli Infection,Infection, E coli,Infection, E. coli,Infection, Escherichia coli
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000890 Anti-Infective Agents Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. Anti-Infective Agent,Anti-Microbial Agent,Antimicrobial Agent,Microbicide,Microbicides,Anti-Microbial Agents,Antiinfective Agents,Antimicrobial Agents,Agent, Anti-Infective,Agent, Anti-Microbial,Agent, Antimicrobial,Agents, Anti-Infective,Agents, Anti-Microbial,Agents, Antiinfective,Agents, Antimicrobial,Anti Infective Agent,Anti Infective Agents,Anti Microbial Agent,Anti Microbial Agents
D001412 Bacillus subtilis A species of gram-positive bacteria that is a common soil and water saprophyte. Natto Bacteria,Bacillus subtilis (natto),Bacillus subtilis subsp. natto,Bacillus subtilis var. natto
D013844 Thiazoles Heterocyclic compounds where the ring system is composed of three CARBON atoms, a SULFUR and NITROGEN atoms. Thiazole
D062105 Molecular Docking Simulation A computer simulation technique that is used to model the interaction between two molecules. Typically the docking simulation measures the interactions of a small molecule or ligand with a part of a larger molecule such as a protein. Molecular Docking,Molecular Docking Simulations,Molecular Docking Analysis,Analysis, Molecular Docking,Docking Analysis, Molecular,Docking Simulation, Molecular,Docking, Molecular,Molecular Docking Analyses,Molecular Dockings,Simulation, Molecular Docking

Related Publications

Fathy M Abdelrazek, and Sobhi M Gomha, and Mohamed E B Shaaban, and Kamal A Rabee, and Heba N El-Shemy, and Abanoub M Abdallah, and Peter Metz
January 2022, European journal of medicinal chemistry,
Fathy M Abdelrazek, and Sobhi M Gomha, and Mohamed E B Shaaban, and Kamal A Rabee, and Heba N El-Shemy, and Abanoub M Abdallah, and Peter Metz
May 2017, Chemistry Central journal,
Fathy M Abdelrazek, and Sobhi M Gomha, and Mohamed E B Shaaban, and Kamal A Rabee, and Heba N El-Shemy, and Abanoub M Abdallah, and Peter Metz
July 2021, Molecules (Basel, Switzerland),
Fathy M Abdelrazek, and Sobhi M Gomha, and Mohamed E B Shaaban, and Kamal A Rabee, and Heba N El-Shemy, and Abanoub M Abdallah, and Peter Metz
January 2005, Organic letters,
Fathy M Abdelrazek, and Sobhi M Gomha, and Mohamed E B Shaaban, and Kamal A Rabee, and Heba N El-Shemy, and Abanoub M Abdallah, and Peter Metz
October 2023, Chemistry & biodiversity,
Fathy M Abdelrazek, and Sobhi M Gomha, and Mohamed E B Shaaban, and Kamal A Rabee, and Heba N El-Shemy, and Abanoub M Abdallah, and Peter Metz
February 2020, European journal of medicinal chemistry,
Fathy M Abdelrazek, and Sobhi M Gomha, and Mohamed E B Shaaban, and Kamal A Rabee, and Heba N El-Shemy, and Abanoub M Abdallah, and Peter Metz
January 2023, Molecules (Basel, Switzerland),
Fathy M Abdelrazek, and Sobhi M Gomha, and Mohamed E B Shaaban, and Kamal A Rabee, and Heba N El-Shemy, and Abanoub M Abdallah, and Peter Metz
January 2015, Bioorganicheskaia khimiia,
Fathy M Abdelrazek, and Sobhi M Gomha, and Mohamed E B Shaaban, and Kamal A Rabee, and Heba N El-Shemy, and Abanoub M Abdallah, and Peter Metz
July 2015, Organic & biomolecular chemistry,
Fathy M Abdelrazek, and Sobhi M Gomha, and Mohamed E B Shaaban, and Kamal A Rabee, and Heba N El-Shemy, and Abanoub M Abdallah, and Peter Metz
July 2014, Organic & biomolecular chemistry,
Copied contents to your clipboard!